Cell-free DNA in Transplant Assessments

 

When:
Presented on January 28, 2020

Continuing education credits available until:
January 28, 2021

Purpose/Goal:

Cell-free DNA (cfDNA) is the term used to describe the small fragments of DNA that occur naturally and circulate in the blood stream. Advanced technology using cfDNA has improved testing and screening options for transplant recipients. Donor-derived cell-free DNA (dd-cfDNA) can assess the amount of cell-free DNA in an organ recipient’s blood that originates from the donor. Elevated levels of cfDNA in the recipient’s blood may signify an increase in cell death from kidney injury and/or rejection. Studies have shown that cfDNA testing is more sensitive and specific than serum creatinine and is able to detect acute rejection at an earlier stage. Join us to hear from genetic testing experts as they discuss cell-free DNA and its potential as a powerful biomarker in transplant assessments.

Learning Objectives:

At the end of the webinar, participants should be able to:

  • Describe cell-free DNA science and its application to patient care.
  • Explain how donor-derived cell-free DNA (dd-cfDNA) can be used in transplant rejection assessment.
  • Recall current literature comparing dd-cfDNA testing to current standard of care in transplant rejection assessment.
  • Summarize how cfDNA technology applications can expand through ongoing research initiatives.

Moderator/Speakers:

  • Phillippe Gauthier, MD, MBA
  • Alexander Wiseman, MD
  • Wade Liu (Moderator)

View Speaker Biographies

Target Audience:
Members of the donation and transplantation community serving diverse populations to include administrators, coordinators, physicians, nurses, surgeons, managers, quality improvement specialists, social workers, and other donation and transplantation center professionals and their colleagues.

Continuing Education:
CEPTC - The Organ Donation and Transplantation Alliance is offering 1.0 Category I CEPTC credit from the American Board for Transplant Certification. Certified clinical transplant and procurement coordinators and certified clinical transplant nurses seeking CEPTC credit must complete the evaluation form within 30 days of viewing the recording.

Nursing - The Organ Donation and Transplantation Alliance is offering 1.0 hour of continuing education credit for this offering, approved by The California Board of Registered Nursing, Provider Number CEP17117. 

 

 

Pricing and FAQs

 

OnDemand Recording - Available Until 1/28/2021: Cell-free DNA in Transplant Assessments

  • Tuesday Jan 28 2020, 3:00 PM - 4:00 PM
UA-58501002-1